GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » Days Sales Outstanding

Privia Health Group (Privia Health Group) Days Sales Outstanding : 69.97 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group Days Sales Outstanding?

Privia Health Group's average Accounts Receivable for the three months ended in Mar. 2024 was $318 Mil. Privia Health Group's Revenue for the three months ended in Mar. 2024 was $415 Mil. Hence, Privia Health Group's Days Sales Outstanding for the three months ended in Mar. 2024 was 69.97.

The historical rank and industry rank for Privia Health Group's Days Sales Outstanding or its related term are showing as below:

PRVA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.9   Med: 40.9   Max: 67.85
Current: 67.85

During the past 6 years, Privia Health Group's highest Days Sales Outstanding was 67.85. The lowest was 35.90. And the median was 40.90.

PRVA's Days Sales Outstanding is ranked worse than
71.61% of 641 companies
in the Healthcare Providers & Services industry
Industry Median: 46.64 vs PRVA: 67.85

Privia Health Group's Days Sales Outstanding increased from Mar. 2023 (53.21) to Mar. 2024 (69.97).


Privia Health Group Days Sales Outstanding Historical Data

The historical data trend for Privia Health Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group Days Sales Outstanding Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 35.90 39.41 40.90 41.30 52.88

Privia Health Group Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.21 64.10 73.25 66.33 69.97

Competitive Comparison of Privia Health Group's Days Sales Outstanding

For the Health Information Services subindustry, Privia Health Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Privia Health Group's Days Sales Outstanding falls into.



Privia Health Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Privia Health Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (189.604 + 290.768) / 2 ) / 1657.737*365
=240.186 / 1657.737*365
=52.88

Privia Health Group's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (290.768 + 346.088) / 2 ) / 415.243*365 / 4
=318.428 / 415.243*365 / 4
=69.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Privia Health Group  (NAS:PRVA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Privia Health Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Privia Health Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group (Privia Health Group) Business Description

Traded in Other Exchanges
N/A
Address
950 N. Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412